Health Advance Inc. (HADV)
USD 0.0
(-14.29%)
USD 0.0
(-14.29%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -49.02 Thousand USD | 81.82% |
| 2023 | -269.65 Thousand USD | -106.38% |
| 2022 | -130.65 Thousand USD | -870.99% |
| 2021 | 16.94 Thousand USD | 0.0% |
| 2016 | -29.5 Thousand USD | 56.32% |
| 2015 | -67.55 Thousand USD | 6.28% |
| 2014 | -72.08 Thousand USD | 16.21% |
| 2013 | -86.02 Thousand USD | 21.19% |
| 2012 | -109.15 Thousand USD | -60.11% |
| 2011 | -68.17 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | -49.02 Thousand USD | 81.82% |
| 2024 Q3 | -11.05 Thousand USD | 4.07% |
| 2024 Q2 | -11.52 Thousand USD | 27.28% |
| 2024 Q1 | -15.84 Thousand USD | -49.59% |
| 2023 Q3 | -20.55 Thousand USD | 84.93% |
| 2023 Q4 | -10.59 Thousand USD | 48.46% |
| 2023 Q2 | -136.39 Thousand USD | -393.51% |
| 2023 FY | -269.65 Thousand USD | -106.38% |
| 2023 Q1 | -27.63 Thousand USD | 0.0% |
| 2022 FY | -130.65 Thousand USD | -870.99% |
| 2022 Q4 | -27.63 Thousand USD | 0.0% |
| 2021 FY | 16.94 Thousand USD | 0.0% |
| 2017 Q1 | -9460.00 USD | 14.91% |
| 2017 Q3 | -74.28 Thousand USD | 0.0% |
| 2016 Q1 | -6076.00 USD | 49.83% |
| 2016 Q3 | -6769.00 USD | -38.74% |
| 2016 Q2 | -4879.00 USD | 19.7% |
| 2016 FY | -29.5 Thousand USD | 56.32% |
| 2016 Q4 | -11.11 Thousand USD | -64.23% |
| 2015 FY | -67.55 Thousand USD | 6.28% |
| 2015 Q4 | -12.11 Thousand USD | -88.19% |
| 2015 Q3 | -6436.00 USD | -0.91% |
| 2015 Q2 | -6378.00 USD | 60.58% |
| 2015 Q1 | -16.17 Thousand USD | 22.76% |
| 2014 Q2 | -19.04 Thousand USD | -11.56% |
| 2014 Q1 | -17.07 Thousand USD | -2.71% |
| 2014 Q4 | -20.94 Thousand USD | 12.9% |
| 2014 FY | -72.08 Thousand USD | 16.21% |
| 2014 Q3 | -24.04 Thousand USD | -26.27% |
| 2013 Q3 | -19.34 Thousand USD | 18.34% |
| 2013 Q2 | -23.68 Thousand USD | 33.47% |
| 2013 Q1 | -35.6 Thousand USD | -0.47% |
| 2013 FY | -86.02 Thousand USD | 21.19% |
| 2013 Q4 | -16.62 Thousand USD | 14.06% |
| 2012 FY | -109.15 Thousand USD | -60.11% |
| 2012 Q2 | -28.72 Thousand USD | -44.25% |
| 2012 Q1 | -19.91 Thousand USD | 41.8% |
| 2012 Q4 | -35.43 Thousand USD | -219.16% |
| 2012 Q3 | -11.1 Thousand USD | 61.35% |
| 2011 FY | -68.17 Thousand USD | 0.0% |
| 2011 Q3 | -26.3 Thousand USD | 0.0% |
| 2011 Q4 | -34.21 Thousand USD | -30.09% |
| 2010 Q4 | - USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | -3703.18 USD | -1223.781% |
| Allstar Health Brands, Inc. | -499.34 Thousand USD | 90.183% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 69.18 Million USD | 100.071% |
| Café Serendipity Holdings, Inc. | -750.15 Thousand USD | 93.465% |
| Decision Diagnostics Corp. | - USD | Infinity% |
| HealthWarehouse.com, Inc. | -1.77 Million USD | 97.236% |
| LIGAND PHARMACEUTICAL INC | 52.15 Million USD | 100.094% |
| MedGen, Inc. | -15.54 USD | -315356.885% |
| Omni Health, Inc. | 1.26 Million USD | 103.873% |
| Oxford Investments Holdings Inc. | -299.1 Thousand USD | 83.61% |
| Pineapple, Inc. | -1.47 Million USD | 96.682% |
| ScripsAmerica, Inc. | -4.73 Million USD | 98.964% |